Triple
T7110943
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Drug Price Competition and Patent Term Restoration Act of 1984 |
E165704
|
entity |
| Predicate | establishes |
P986
|
FINISHED |
| Object |
Abbreviated New Drug Application process
The Abbreviated New Drug Application process is the U.S. regulatory pathway that allows generic drug manufacturers to gain FDA approval by demonstrating bioequivalence to an already approved brand-name drug without repeating full clinical trials.
|
E642120
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69c6888120f081908f8f01b201dc4a4c |
elicitation | completed |
| NER | batch_69c6e5ecd4488190bf19e42de55da98b |
ner | completed |
| NED1 | batch_69c79cb8d4988190945516cee5d6d53b |
ned_source_triple | completed |
| NED2 | batch_69c79df3f5648190981176b6c9791181 |
ned_description | completed |
| NEDg | batch_69c79d3feacc819097887064a7439340 |
nedg | completed |
Created at: March 27, 2026, 2:43 p.m.